Infectious Diseases in Critical Care Medicine

(ff) #1

  1. http://www.cdc.gov/ncidod/dhqp/ar_mrsa.html. Accessed on February 2009.

  2. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired
    methicillin-resistantStaphylococcus aureusisolates of diverse genetic backgrounds. J Infect Dis
    2002;186(9):1344–1347.

  3. Salmenlinna S, Lyytika ̈inen O, Vuopio-Varkila J. Community-acquired methicillin-resistantStaph-
    ylococcus aureus, Finland. Emerg Infect Dis 2002;8(6):602–607.

  4. O ̈sterlund A, Kahlmeter G, Bieber L, et al. Intrafamilial spread of highly virulentStaphylococcus aureus
    strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis 2002;34(10):763–764.

  5. Liassine N, Auckenthaler R, Descombes M-C, et al. Community-acquired methicillin-resistant
    Staphylococcus aureusisolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative
    toxin genes. J Clin Microbiol 2004;42(2):825–828.

  6. Stemper ME, Shukla SK, Reed KD. Emergence and spread of community-associated methicillin-
    resistantStaphylococcus aureusin rural Wisconsin, 1989 to 1999. J Clin Microbiol 2004;42(12):5673–5680.

  7. Diep BA, Sensabaugh GF, Somboona NS, et al. Widespread skin and soft-tissue infections due to two
    methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine
    Leukocidin. J Clin Microbiol 2004;42(5):2080–2084.

  8. Cooms GW, Nimmo GR, Bell JM, et al. Genetic diversity among community methicillin-resistant
    Staphylococcus aureusstrains causing outpatient infections in Australia. J Clin Microbiol 2004;42(10):
    4735–4743.

  9. Witte W, Braulke C, Cuny C, et al. Emergence of methicillin-resistantStaphylococcus aureuswith
    Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005;24(1):1–5.

  10. Lu P-L, Chin L-C, Peng C-F, et al. Risk factors and molecular analysis of community methicillin-
    resistantStaphylococcus aureuscarriage. J Clin Microbiol 2005;43(1):132–139.

  11. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistantStaphylococcus
    aureuscolonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J
    2001;20(8):763–767.

  12. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired
    methicillin-resistantStaphylococcus aureusin Minnesota 1996-1998. Clin Infect Dis 2001;33(7):990–996.

  13. Fridkin SK, Hagerman JC, Morrison M, et al. methicillin-resistantStaphylococcus aureusdisease in
    three communities. N Engl J Med 2005;352(14):1436–1444.

  14. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive
    methicillin-resistantStaphylococcus aureus, 2006. Emerg Infect Dis 2007;13(4):594–600.

  15. Kennedy AD, Otto M, Braughton KR, et al. Epidemic community-associated methicillin-resistant
    Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 2008;
    105(4):1327–1332.

  16. Davis SL, Rybak MJ, Amjad M, et al. Characteristics of patients with healthcare-associated infection
    due to SCCmec. Type IV methicillin-resistantStaphylococcus aureus. Infect Control Hosp Epidemiol
    2006;27(10):1025–1031.

  17. Patel M, Waites KB, Hoesley CJ, et al. Emergence of USA300 MRSA in a tertiary medical centre:
    implications for epidemiological studies. J Hosp Infect 2008;68(3):208–213.

  18. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistantStaphylococcus
    aureus(MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008;46(6):
    787–794.

  19. Seybold U, Halvosa JS, White N, et al. Emergence of and risk factors for methicillin-resistant
    Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics 2008;122(5):
    1039–1046.

  20. D’Agata EMC, Webb GF, Horn MA, et al. Modeling the invasion of community-acquired methicillin-
    resistantStaphylococcus aureusinto hospitals. Clin Infect Dis 2009;48(3):274–284.

  21. Uttley AH, Collins CH, Naidoo J, et al. Vancomycin-resistant enterococci. Lancet 1988;1(1):57–58.

  22. Leclercq R, Derlot E, Fuval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in
    Enterococcus faecium. N Engl J Med 1998;319(3):157–161.

  23. Nosocomial enterococci resistant to vancomycin—United States, 1989–1993. MMWR Morb Mortal
    Wkly Rep 1993;42(30):597–600.

  24. Centers for Disease Control and Prevention. National Nosocomial Infectious Surveillance (NNIS)
    system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect
    Control 2004;32(12):470–485.

  25. Montecalvo MA, de Lencastre H, Carraher M, et al. Natural history of colonization with
    vancomycin-resistantEnterococcus faecium. Infect Control Hosp Epidemiol 1995;16(12):680–685.

  26. Henning KJ, de Lencastre H, Eagan J, et al. Vancomycin-resistantEnterococcus faeciumon a pediatric
    oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J
    1996;15(10):848–854.


120 Mayhall

Free download pdf